Back
BioCryst Pharmaceuticals, Inc. Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Buy
59
BCRX
BioCryst Pharmaceuticals, Inc.
Last Price:
$9.03
Seasonality Move:
15.89%
7 Day Trial
ALL ACCESS PASS
$
7
-
The current trend is moderately bearish and BCRX is experiencing selling pressure, which indicates risk of future bearish movement.
BioCryst Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 9.42 | Sell |
| 20-day SMA: | 9.16 | Sell |
| 50-day SMA: | 7.98 | Buy |
| 200-day SMA: | 7.88 | Buy |
| 8-day EMA: | 9.34 | Sell |
| 20-day EMA: | 9.09 | Sell |
| 50-day EMA: | 8.4 | Buy |
| 200-day EMA: | 7.91 | Buy |
BioCryst Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.38 | Buy |
| Relative Strength Index (14 RSI): | 52.42 | Buy |
| Chaikin Money Flow: | -4182320 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (8.57 - 9.55) | Sell |
| Bollinger Bands (100): | (6.71 - 8.57) | Buy |
BioCryst Pharmaceuticals, Inc. Technical Analysis
| Mar 20 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 30 | Mar 31 | Apr 1 | Apr 2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | Apr | |||||||||
| 20 | 23 | 24 | 25 | 26 | 27 | 30 | 31 | 01 | 02 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioCryst Pharmaceuticals, Inc. Stock
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 9.02 while BCRX 8-day simple moving average is 9.42, which is a Sell signal.
-
The stock price of BCRX is 9.02 while BioCryst Pharmaceuticals, Inc. 20-day SMA is 9.16, which makes it a Sell.
-
BioCryst Pharmaceuticals, Inc. 50-day simple moving average is 7.98 while BCRX share price is 9.02, making it a Buy technically.
-
BCRX stock price is 9.02 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 7.88, creating a Buy signal.
BCRX Technical Analysis vs Fundamental Analysis
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
Is BioCryst Pharmaceuticals, Inc. a Buy or a Sell?
-
BioCryst Pharmaceuticals, Inc. stock is rated a BuyThe current BioCryst Pharmaceuticals, Inc. [BCRX] share price is $9.02. The Score for BCRX is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
BioCryst Pharmaceuticals, Inc. Stock Info
Market Cap:
2.2B
Price in USD:
9.02
Share Volume:
7.8M
BioCryst Pharmaceuticals, Inc. 52-Week Range
52-Week High:
11.31
52-Week Low:
6.00
Buy
59
BioCryst Pharmaceuticals, Inc. (BCRX)
is a Buy
BioCryst Pharmaceuticals, Inc. Share Price Forecast
-
What is the BioCryst Pharmaceuticals, Inc. stock price today?The BioCryst Pharmaceuticals, Inc. stock price is 9.02 USD today.
-
Will BCRX stock go up or go down?BioCryst Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is BioCryst Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioCryst Pharmaceuticals, Inc. is not overvalued.
Is BioCryst Pharmaceuticals, Inc. Stock a Buy?
-
BioCryst Pharmaceuticals, Inc. share price is 9.02 while BCRX 8-day exponential moving average is 9.34, which is a Sell signal.
-
The stock price of BCRX is 9.02 while BioCryst Pharmaceuticals, Inc. 20-day EMA is 9.09, which makes it a Sell.
-
BioCryst Pharmaceuticals, Inc. 50-day exponential moving average is 8.40 while BCRX share price is 9.02, making it a Buy technically.
-
BCRX stock price is 9.02 and BioCryst Pharmaceuticals, Inc. 200-day simple moving average is 7.91, creating a Buy signal.
Fundamental Analysis of BioCryst Pharmaceuticals, Inc.
Is BioCryst Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.06 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.01 per share, and an increase next year of $0.32 per share.
Technical Analysis of BioCryst Pharmaceuticals, Inc.
Should I short BioCryst Pharmaceuticals, Inc. stock?
-
BCRX Moving Average Covergence Divergence (MACD) indicator is 0.38, suggesting BioCryst Pharmaceuticals, Inc. is a Buy
-
BioCryst Pharmaceuticals, Inc. Relative Strength Index (RSI) is 52.42, which suggest BioCryst Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for BioCryst Pharmaceuticals, Inc. is (8.57 - 9.55), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for BioCryst Pharmaceuticals, Inc. is (6.71 - 8.57), which suggest BioCryst Pharmaceuticals, Inc. is a Buy
* BioCryst Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.